High expression of PRMT1 has been linked to poor overall survival in many types of cancers; conversely, inhibition of PRMT1 activity blocks the proliferation of leukemia and solid tumors such as lung, breast, and ovarian cancers. This evidence concerns the gene PRMT1 and ovarian cancer.